These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 17354610

  • 1. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis.
    Ohta H, Tanimoto T, Taniai M, Taniguchi M, Ariyasu T, Arai S, Ohta T, Fukuda S.
    In Vivo; 2007; 21(1):25-32. PubMed ID: 17354610
    [Abstract] [Full Text] [Related]

  • 2. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.
    Martinez A, Regadera J, Jimenez E, Santos I, Gargallo-Viola D.
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1008-13. PubMed ID: 11257009
    [Abstract] [Full Text] [Related]

  • 3. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
    Netea MG, van Tits LJ, Curfs JH, Amiot F, Meis JF, van der Meer JW, Kullberg BJ.
    J Immunol; 1999 Aug 01; 163(3):1498-505. PubMed ID: 10415052
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of farnesol against oral candidiasis in mice.
    Hisajima T, Maruyama N, Tanabe Y, Ishibashi H, Yamada T, Makimura K, Nishiyama Y, Funakoshi K, Oshima H, Abe S.
    Microbiol Immunol; 2008 Jul 01; 52(7):327-33. PubMed ID: 18667031
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY).
    Ibrahim el-SM, Rahman AK, Isoda R, Umeda K, Van Sa N, Kodama Y.
    Vaccine; 2008 Apr 16; 26(17):2073-80. PubMed ID: 18375022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense.
    Steinshamn S, Bemelmans MH, van Tits LJ, Bergh K, Buurman WA, Waage A.
    J Immunol; 1996 Sep 01; 157(5):2155-9. PubMed ID: 8757341
    [Abstract] [Full Text] [Related]

  • 16. Tumor necrosis factor and Candida albicans.
    Djeu JY.
    Behring Inst Mitt; 1991 Feb 01; (88):222-7. PubMed ID: 2049042
    [Abstract] [Full Text] [Related]

  • 17. Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-alpha- and lymphotoxin-alpha-deficient mice.
    Vonk AG, Netea MG, van Krieken JH, van der Meer JW, Kullberg BJ.
    J Infect Dis; 2002 Dec 15; 186(12):1815-22. PubMed ID: 12447768
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha.
    Matuschak GM, Lechner AJ.
    Crit Care Med; 1997 Jan 15; 25(1):111-20. PubMed ID: 8989186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.